These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17636596)

  • 1. WITHDRAWN: Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2007 Jul; 2003(4):CD000129. PubMed ID: 17636596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2003; (1):CD000129. PubMed ID: 12535387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2000; (2):CD000129. PubMed ID: 10796492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines for preventing malaria (SPf66).
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2006 Apr; 2006(2):CD005966. PubMed ID: 16625647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines for preventing malaria (blood-stage).
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD006199. PubMed ID: 17054281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for preventing malaria (pre-erythrocytic).
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD006198. PubMed ID: 17054280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy trial of malaria vaccine SPf66 in Gambian infants.
    D'Alessandro U; Leach A; Drakeley CJ; Bennett S; Olaleye BO; Fegan GW; Jawara M; Langerock P; George MO; Targett GA
    Lancet; 1995 Aug; 346(8973):462-7. PubMed ID: 7637479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune responses during a malaria vaccine trial in Tanzanian infants.
    Galindo CM; Acosta CJ; Schellenberg D; Aponte JJ; Roca A; Oettli A; Urassa H; Armstrong Schellenberg J; Kahigwa E; Ascaso C; Mshinda H; Lwilla F; Vidal J; Menendez C; Tanner M; Alonso PL
    Parasite Immunol; 2000 Sep; 22(9):437-43. PubMed ID: 10972850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2015 Feb; (2):CD008152. PubMed ID: 25693791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2014 Jun; (6):CD008152. PubMed ID: 24979199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficacy trial of the malaria vaccine SPf66 in Gambian infants--second year of follow-up.
    Bojang KA; Obaro SK; D'Alessandro U; Bennett S; Langerock P; Targett GA; Greenwood BM
    Vaccine; 1998 Jan; 16(1):62-7. PubMed ID: 9607010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of malaria vaccines: SPf66--what next?
    Tanner M; Alonso PL
    Schweiz Med Wochenschr; 1996 Jul; 126(27-28):1210-5. PubMed ID: 8766632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania.
    Acosta CJ; Galindo CM; Schellenberg D; Aponte JJ; Kahigwa E; Urassa H; Schellenberg JR; Masanja H; Hayes R; Kitua AY; Lwilla F; Mshinda H; Menendez C; Tanner M; Alonso PL
    Trop Med Int Health; 1999 May; 4(5):368-76. PubMed ID: 10402973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66.
    Haywood M; Conway DJ; Weiss H; Metzger W; D'Alessandro U; Snounou G; Targett G; Greenwood B
    Trans R Soc Trop Med Hyg; 1999 Feb; 93 Suppl 1():65-8. PubMed ID: 10450429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of SPf66 malaria vaccine efficacy in Brazil.
    Urdaneta M; Prata A; Struchiner CJ; Tosta CE; Tauil P; Boulos M
    Am J Trop Med Hyg; 1998 Mar; 58(3):378-85. PubMed ID: 9546423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum.
    Alonso PL; Smith TA; Armstrong-Schellenberg JR; Kitua AY; Masanja H; Hayes R; Hurt N; Font F; Menendez C; Kilama WL; Tanner M
    J Infect Dis; 1996 Aug; 174(2):367-72. PubMed ID: 8699068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria.
    al-Yaman F; Genton B; Anders R; Taraika J; Ginny M; Mellor S; Alpers MP
    Parasite Immunol; 1995 Sep; 17(9):493-501. PubMed ID: 8552419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.
    Bojang KA; Milligan PJ; Pinder M; Vigneron L; Alloueche A; Kester KE; Ballou WR; Conway DJ; Reece WH; Gothard P; Yamuah L; Delchambre M; Voss G; Greenwood BM; Hill A; McAdam KP; Tornieporth N; Cohen JD; Doherty T;
    Lancet; 2001 Dec; 358(9297):1927-34. PubMed ID: 11747915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.